missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Anticuerpos
  4. Anticuerpos primarios
  5. Todos los anticuerpos primarios
  6. 18583425

PD-L2/B7-DC/PDCD1LG2 Antibody (988708) [DyLight 680], Novus Biologicals™

Mouse Monoclonal Antibody

Marca:  Novus Biologicals FAB12241Y

Código de producto. 18583425

  • ONLINE EXCLUSIVE PRICE
    664.00€
    627.90€ / 0.10 ml
    Ahorro 36.10€
    5% Descuento

Por favor, para comprar este producto. ¿No tiene usuario web? Regístrese hoy mismo.

Este artículo no se puede devolver. Vea la política de devoluciones

Descripción

Descripción

PD-L2/B7-DC/PDCD1LG2 Monoclonal antibody specifically detects PD-L2/B7-DC/PDCD1LG2 in Human samples. It is validated for Flow Cytometry
TRUSTED_SUSTAINABILITY
Especificaciones

Especificaciones

PD-L2/B7-DC/PDCD1LG2
Monoclonal
DyLight 680
50mM Sodium Borate
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Human
Purified
Flow Cytometry
988708
Flow Cytometry
B7-DC, bA574F11.2, Btdc, Butyrophilin B7-DC, CD273 antigen, CD273PD-1 ligand 2, MGC142240, PD-1-ligand 2, PDCD1L2MGC142238, PDL2B7DC, PD-L2PDCD1 ligand 2, programmed cell death 1 ligand 2, Programmed death ligand 2
Mouse myeloma cell line NS0-derived recombinant human PD-L2/B7-DC, Met1-Pro219, Accession # Q9BQ51
0.1 mL
Apoptosis
80380
Store at 4°C in the dark.
IgG2b
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.